Back to News
Market Impact: 0.6

Deaths, pregnancy loss linked to recalled pasta sold at Walmart and Kroger

WMTKRCOSTFOXA
Pandemic & Health EventsConsumer Demand & RetailHealthcare & BiotechRegulation & LegislationCompany Fundamentals
Deaths, pregnancy loss linked to recalled pasta sold at Walmart and Kroger

FreshRealm has recalled Marketside and Home Chef chicken fettuccine Alfredo products sold at Walmart and Kroger due to potential Listeria contamination, linked to three deaths and one pregnancy loss. The recalled products, produced before June 17 and sold in the refrigerated sections, have prompted warnings from the FSIS and CDC urging consumers to discard or return the items; seventeen illnesses across thirteen states have been reported between August 2023 and May 2024. While Walmart shares are up, Kroger shares are slightly down following the announcement.

Analysis

A significant food safety incident has emerged involving FreshRealm, a supplier to major retailers Walmart and Kroger, triggering a recall of 'ready-to-eat' chicken fettuccine Alfredo products under the Marketside (Walmart) and Home Chef (Kroger) brands due to Listeria contamination. The outbreak, linked to products produced before June 17, has resulted in severe health consequences, including three reported deaths, one pregnancy loss, and 17 illnesses across 13 states between August 2023 and May 2024. Regulatory bodies including the U.S. Food Safety and Inspection Service (FSIS), Centers for Disease Control and Prevention (CDC), and the Food & Drug Administration (FDA) are actively investigating, though the precise source of contamination remains undetermined. Despite the strongly negative overall sentiment (-0.85) and a specific negative sentiment of -0.7 for both retailers, Walmart's stock (WMT) saw a modest increase of +0.94%, while Kroger's stock (KR) experienced a slight decline of -0.65% post-announcement. This recall poses potential reputational damage and financial risks for both retailers through their private-label brands, with the market impact score of 0.6 indicating a moderate level of investor concern regarding the broader implications of this health event and associated regulatory scrutiny.

AllMind AI Terminal